
The Dangerous Promise of Speed: How AI Brought a Drug to Phase III in 4.5 Years
MindRank has dosed its first patient in Phase III with MDR-001, an AI-designed oral GLP-1. This milestone accelerates not just science but organizational truths.
Simón Arce6 min

